[HTML][HTML] Safety and efficacy of COVID-19 prime-boost vaccinations: homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed …

…, E Alalawi, AM Mohamed, AE Butler, B Alalawi… - Vaccine, 2023 - Elsevier
Background Booster vaccine doses against SARS-CoV-2 have been advocated to address
evidence of waning immunity, breakthrough infection, and the emergence of immune-…

Comparison of SARS-COV-2 nasal antigen test to nasopharyngeal RT-PCR in mildly symptomatic patients

…, F Mustafa, AI AlAwadhi, Q Alansari, B AlAlawi… - MedRxiv, 2020 - medrxiv.org
Introduction COVID 19 has been vastly spreading since December 2019 and the medical
teams worldwide are doing their best to limit its spread. In the absence of a vaccine the best …

[HTML][HTML] Evaluation of rapid antigen tests using nasal samples to diagnose SARS-CoV-2 in symptomatic patients

…, F Mustafa, AI Alawadhi, B Alalawi… - Frontiers in Public …, 2022 - frontiersin.org
Introduction The best way to mitigate an outbreak besides mass vaccination is via early
detection and isolation of infected cases. As such, a rapid, cost-effective test for the early …

Safety and immunogenicity of COVID-19 BBIBP-CorV vaccine in children 3–12 years old

…, B Alsaffar, E Alalawi, A Alsayyad, A Merza, B Alalawi… - Vaccines, 2022 - mdpi.com
Background and Objectives: In the current COVID-19 pandemic, children below the age of 12
could manifest COVID-19 symptoms and serve as a reservoir for the virus in the community…

Comparing the Safety and Immunogenicity of homologous (Sputnik V) and heterologous (BNT162B2) COVID-19 prime-boost vaccination

…, A Mirza, B Alsaffar, E AlAlawi, K Fakhroo, B Alalawi… - MedRxiv, 2022 - medrxiv.org
Studies have shown increased immunogenicity from heterologous boosting. This study
specifically assessed boosting with Pfizer-BioNTech in Sputnik V vaccination regimens. …

Awareness of heart attack symptoms among Bahraini adults attending primary healthcare centers.

S Alsooreti, B Alalawi, H Abdulkarim, S Mohamed… - 2018 - cabidigitallibrary.org
Background and objectives: Worldwide, mortality due to cardiovascular diseases (CVD) is a
concern of great magnitude. The mortality rate in Bahrain, due to CVD, was 19.5%, 32%, …

Comparison of SARS-COV-2 nasal antigen test to nasopharyngeal RT-PCR in mildly symptomatic patients (preprint)

…, F Mustafa, AI AlAwadhi, Q Alansari, B AlAlawi… - 2020 - pesquisa.bvsalud.org
Introduction COVID 19 has been vastly spreading since December 2019 and the medical
teams worldwide are doing their best to limit its spread. In the absence of a vaccine the best …

From Likes To Lifesavers: The Social Media Revolution In Saudi Arabian Health Promotion; Review Of Literature

…, FSR Zainy, MH Alalawi… - Journal of Namibian …, 2023 - namibian-studies.com
Background: The use of social media for health education and promotion has gained significance
in Saudi Arabia due to its widespread internet and social media usage. Understanding …

[HTML][HTML] Evaluation of an adjusted MEWS (Modified Early Warning Score) for COVID-19 patients to identify risk of ICU admission or death in the Kingdom of Bahrain

…, S Alkhawaja, AM Al Balooshi, M Alalawi… - Journal of Infection and …, 2023 - Elsevier
Background While most COVID-19 cases have uncomplicated infection, a small proportion
has the potential to develop life-threatening disease, as such development of a prediction …

[PDF][PDF] Safety and Efficacy of COVID-19 Prime-Boost Vaccinations: Homologous BBIBP-CorV versus Heterologous BNT162b2 Boosters in BBIBP-CorV-Primed …

SA Kumar, M Alqahtani - researchgate.net
With over half a billion cases and 6 million deaths in the first two years since the start of the
SARS-CoV-2 (COVID-19) pandemic1, together with the superimposed global economic …